Tetrameric c-di-GMP Mediates Effective Transcription Factor Dimerization to Control Streptomyces Development  by Tschowri, Natalia et al.
Tetrameric c-di-GMPMediates Effective
Transcription Factor Dimerization
to Control Streptomyces Development
Natalia Tschowri,1,3,4 Maria A. Schumacher,2,4 Susan Schlimpert,1 Naga babu Chinnam,2 Kim C. Findlay,1
Richard G. Brennan,2 and Mark J. Buttner1,*
1Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK
2Department of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA
3Present address: Institute for Biology/Microbiology, Humboldt University, 10115 Berlin, Germany
4Co-first author
*Correspondence: mark.buttner@jic.ac.uk
http://dx.doi.org/10.1016/j.cell.2014.07.022
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARY
The cyclic dinucleotide c-di-GMP is a signalingmole-
cule with diverse functions in cellular physiology.
Here, we report that c-di-GMP can assemble into a
tetramer that mediates the effective dimerization of
a transcription factor, BldD, which controls the pro-
gression of multicellular differentiation in sporulating
actinomycete bacteria. BldD represses expression
of sporulation genes during vegetative growth in a
manner that depends on c-di-GMP-mediated dimer-
ization. Structural and biochemical analyses show
that tetrameric c-di-GMP links two subunits of BldD
through their C-terminal domains, which are other-
wise separated by 10 A˚ and thus cannot effect
dimerization directly. Binding of the c-di-GMP
tetramer by BldD is selective and requires a bipartite
RXD-X8-RXXD signature. The findings indicate a
unique mechanism of protein dimerization and the
ability of nucleotide signaling molecules to assume
alternative oligomeric states to effect different
functions.
INTRODUCTION
In all domains of life, nucleotide-based second messengers
allow a rapid integration of external and internal signals into
fine-tuned regulatory pathways that control cellular responses
to changing conditions. As a unifying theme, a basic second
messenger control module consists of two distinct enzymes
for synthesis and degradation of the second messenger and a
nucleotide sensor that, upon ligand binding, interacts with a
target to produce a cellular output (Hengge, 2009). 30, 50-cyclic
diguanylic acid (c-di-GMP), which is not produced in archaea
or eukaryotes, was first discovered as an allosteric effector of
cellulose synthase in Gluconacetobacter xylinus and is now
recognized as one of the most important and widespread sec-1136 Cell 158, 1136–1147, August 28, 2014 ª2014 The Authorsond messengers in bacteria. c-di-GMP is synthesized from two
molecules of GTP by diguanylate cyclases (DGCs), which are
characterized by active site GGDEF motifs (A-site) (Paul et al.,
2004; Chan et al., 2004). The majority of active DGCs also carry
a so-called inhibitory or I-site motif, RxxD, which is involved in
feedback inhibition (Christen et al., 2006; Schirmer and Jenal,
2009). Specific phosphodiesterases (PDEs), which harbor EAL
or HD-GYP domains, degrade the cyclic dinucleotide (Schmidt
et al., 2005; Christen et al., 2005; Ryan et al., 2006). The enzy-
matically active domains involved in c-di-GMP turnover are often
associated with diverse sensory domains, thus enabling cells to
adjust secondmessenger levels in response to different environ-
mental stimuli (Hengge, 2009).
The binding of c-di-GMP to effector proteins impacts diverse
processes such as adhesion, virulence, motility, and biofilm for-
mation in unicellular, flagellated bacteria (Ro¨mling et al., 2013).
The known c-di-GMP-binding motifs of these proteins are limited
but include degenerate GGDEF domain proteins carrying I-site
motifs (Duerig et al., 2009; Lee et al., 2007b; Petters et al.,
2012), inactive EAL domain receptors (Navarro et al., 2009; Qi
et al., 2011; Newell et al., 2009), and PilZ domain-containing pro-
teins (Amikam and Galperin, 2006). Transcription factors that
sense c-di-GMP lack these common c-di-GMP-binding motifs
and thus must be identified experimentally. The sparse list of
known c-di-GMP-responsive transcriptional regulators includes
the TetR-like activator LtmA from Mycobacterium smegmatis (Li
and He, 2012), the CRP-FNR-like transcription factor Clp from
Xanthomonas (Chin et al., 2010; Leduc and Roberts, 2009),
Bcam1349 from Burkholderia (Fazli et al., 2011), the NtrC-type
protein FleQ from Pseudomonas aeruginosa (Baraquet and Har-
wood, 2013), and VpsR from Vibrio cholerae (Srivastava et al.,
2011). The only c-di-GMP-responsive transcription factor for
which structural information is available and hence c-di-GMP
binding is understood is VpsT,which is amember of thewell-stud-
ied FixJ-LuxR-CsgD family of response regulators. The VpsT
structure revealed a characteristic response regulator fold and a
W(F/L/M)(T/S)R c-di-GMP-binding motif (Krasteva et al., 2010).
Notably, in all known structures of c-di-GMP-binding effector
proteins or enzymes, the c-di-GMP is bound either as a monomer
Figure 1. c-di-GMP Levels Affect S. venezuelae Development
(A) Domain organization of predicted active c-di-GMP-metabolizing proteins in S. venezuelae. GGDEF domains are shown as red boxes. Amino acids different
from the conserved product inhibition site (RxxD) are shown in red. Noncanonical residues of the EAL domains (blue box) and HD-GYP domains (green box) are
highlighted in red. Predicted transmembrane helices are shown as black bars, and N-terminal GAF, PAS, and PAC signaling domains are boxed in black.
(B) Overexpression of CdgB (a DGC from S. coelicolor) or YhjH (a PDE from E. coli) from the ermEp* promoter in S. venezuelae results in loss of aerial mycelium
formation.
(C) SEMs reveal that while CdgB overexpression blocks development (giving rise to a classic ‘‘bald’’ phenotype; middle), YhjH overexpression (right) induces
precocious hypersporulation without formation of aerial hyphae. Spore-bearing aerial hyphae of the WT are shown for comparison (left). Cells were grown on
maltose-yeast extract-malt extract (MYM) agar for four days at 30C prior to imaging.
See also Figure S1.or intercalated dimer. Biophysical studies suggest the possibility
of higher order oligomeric forms of c-di-GMP, but they have yet
to be observed in any biological context (Gentner et al., 2012).
While the roles played by c-di-GMP in controlling cellular
processes in unicellular bacteria are becoming clear, the func-
tion(s) of c-di-GMP in multicellular, nonmotile bacteria such as
Streptomyces are unknown. The complex Streptomyces life cy-
cle involves two distinct filamentous cell forms: the growing or
vegetative hyphae and the reproductive or aerial hyphae, which
differentiate into exospores for dispersion through a massive
synchronous septation event (Fla¨rdh and Buttner, 2009). In the
model speciesStreptomyces venezuelae, there are threeGGDEF
proteins, two proteins with HD-GYP domains, and five proteins
containing both aGGDEF and an EAL domain (Figure 1A). Altered
expression of the GGDEF proteins, CdgA and CdgB, and dele-
tions of the EAL proteins, RmdA and RmdB, have a significant
impact on Streptomyces growth progression, suggesting that
c-di-GMP plays a role in controlling developmental processes
in multicellular bacteria (den Hengst et al., 2010; Tran et al.,
2011; Hull et al., 2012). Interestingly, cdgA and cdgB haverecently been identified as direct regulatory targets of the devel-
opmental master regulator BldD (den Hengst et al., 2010; Tran
et al., 2011). Mutations in the bld loci block the formation of aerial
hyphae, resulting in a ‘‘bald’’ phenotype, and also affect the pro-
duction of antibiotics (McCormick and Fla¨rdh, 2012).
BldD sits at the top of the regulatory cascade controlling
development, serving to repress expression of sporulation genes
during vegetative growth (den Hengst et al., 2010). In Strepto-
myces coelicolor, BldD controls the expression of at least 167
genes, including 42 genes (25% of the regulon) that encode
regulatory proteins (Elliot et al., 2001; den Hengst et al., 2010).
Among these BldD targets are many genes known to play critical
roles in Streptomyces development, including other bld regula-
tors (e.g., bldA, bldC, bldH/adpA, bldM, and bldN), several whi
(white) regulators required for the differentiation of aerial hyphae
into spores (e.g., whiG and whiB), and genes encoding critical
components of the cell division and chromosome segregation
machineries such as FtsZ, SsgA, SsgB, and the DNA translocase
SffA (den Hengst et al., 2010; McCormick, 2009). How BldD
activity is regulated, however, has been unknown.Cell 158, 1136–1147, August 28, 2014 ª2014 The Authors 1137
Here we show that BldD is a c-di-GMP-binding effector pro-
tein, thus revealing a link between c-di-GMP signaling and the
development of multicellular bacteria. Specifically, structural
and biochemical analyses show that the second messenger
c-di-GMP activates BldD DNA binding by driving a unique form
of dimerization that is mediated by a tetrameric form of c-di-
GMP. The c-di-GMP tetramer performs its oligomerization func-
tion by adjoining two BldD C-terminal domain (CTD) protomers,
the polypeptide chains of which are separated by 10 A˚. BldD
recognizes the c-di-GMP tetramer using a bipartite RXD-X8-
RXXD c-di-GMP interaction signature sequence from each
subunit. Thus, tetrameric c-di-GMP acts as a small-molecule
dimerizing agent that controls the DNA-binding activity of
BldD, leading to repression of the BldD regulon of sporulation
genes during vegetative growth, thereby controlling the hypha-
to-spore transition in multicellular bacteria.
RESULTS
c-di-GMPControlsDevelopmental ProgramProgression
in Streptomyces venezuelae
To gain insight into the cellular processes controlled by c-di-
GMP in streptomycetes, we overexpressed either the active
DGC CdgB from S. coelicolor (Tran et al., 2011) or the active
PDE YhjH from E. coli (Pesavento et al., 2008). Strikingly, overex-
pression of both CdgB and YhjH blocked the generation of aerial
mycelium by S. venezuelae (Figure 1B). However, scanning elec-
tron micrographs (SEMs) revealed that, whereas overexpression
of CdgB blocked development, resulting in a classical bald
phenotype, overexpression of the PDE YhjH in fact promoted
sporulation, but the colonies appeared bald to the naked eye
because aerial mycelium formation had been bypassed (Fig-
ure 1C). As judged by heat resistance, the spores made by the
YhjH overexpression strain were as robust as those of the wild-
type (WT) (Figure S1A available online). Moreover, overexpres-
sion of catalytically inactive versions of YhjH or CdgB had no
effect on S. venezuelae development (Figure S1B). These data
suggest that intracellular levels of c-di-GMP influence the timing
of development. In particular, they suggest that increased c-di-
GMP levels delay differentiation, arresting the colonies in the
vegetative growth stage, whereas decreased levels of the sec-
ond messenger accelerate development, favoring sporulation.
BldD Is a c-di-GMP Effector Protein
S. venezuelae has no PilZ domain-containing proteins, and no
putative c-di-GMP-binding effector proteins have so far been
identified in the Streptomyces genus. Thus, to address the
mechanism by which S. venezuelae senses c-di-GMP to control
sporulation, we sought to identify c-di-GMP effector proteins
involved in development. To selectively enrich putative c-di-
GMP-binding proteins from S. venezuelae cell extracts, we per-
formed an affinity pull-down assay using a c-di-GMP capture
compound (Nesper et al., 2012). Captured proteins were identi-
fied by tryptic mass spectrometry fingerprinting.
Remarkably, the developmental master regulator BldD was
repeatedly recovered in our c-di-GMP-based capture com-
pound experiments. BldD is an 18 kDa DNA-binding protein
(Elliot and Leskiw, 1999) consisting of two distinct domains con-1138 Cell 158, 1136–1147, August 28, 2014 ª2014 The Authorsnected by a flexible linker (Figure 2A). The N-terminal domain is
the DNA-binding domain (DBD) and has a xenobiotic response
element (XRE) helix-turn-helix (HTH) DNA-binding motif (Kim
et al., 2006). The BldD CTD harbors a largely helical fold with
no known function (Kim et al., 2014). To probe the interaction
between BldD and c-di-GMP further and to identify the c-di-
GMP-binding domain, we used differential radial capillary action
of ligand assays (DRaCALA) (Roelofs et al., 2011). DRaCALA al-
lows the visualization of protein-bound radiolabeled ligand as a
concentrated spot after the application of the protein-ligand
mixture onto nitrocellulose. Using this assay, we confirmed
that full-length (FL) BldD (expressed as an N-terminally His6-
tagged protein) from both S. venezuelae (Figures 2B and S2B)
and S. coelicolor (data not shown) bind 32P-labeled c-di-GMP.
Importantly, the DRaCALA assays demonstrated that the previ-
ously uncharacterized CTD of BldD functions as the c-di-GMP-
binding domain (Figure 2B). Further, excess unlabeled c-di-
GMP, but not GTP, competed with the labeled c-di-GMP for
binding to FL BldD and to BldD-CTD. Thus, these data reveal
that the CTD of the key developmental regulator BldD is a c-di-
GMP-binding domain.
Cyclic di-GMP Enhances Binding of BldD to Its Target
Promoters In Vitro and In Vivo
Using global chromatin immunoprecipitation-microarray anal-
ysis (ChIP-chip), we previously identified the complete BldD
regulon in S. coelicolor, showing that it encompasses167 tran-
scription units (den Hengst et al., 2010). Through MEME-based
sequence analysis of all the promoter regions directly targeted
by BldD, we defined a 13 bp pseudo-palindromic sequence,
50-TNAC(N)5GTNA-30, designated the BldD box, which functions
as a specific binding sequence for BldD (denHengst et al., 2010).
Sequence analysis showed that the BldD box was conserved
between S. coelicolor and S. venezuelae for most key BldD
target promoters (den Hengst et al., 2010). Further, BldD from
S. coelicolor and S. venezuelae contain an identical DBD and
differ by only two residues in the DBD-CTD linker and five resi-
dues in the CTD, suggesting that BldD function is broadly
conserved between the two species.
Having shown that BldD binds c-di-GMP, we tested the effect
of c-di-GMP on BldD DNA binding. Radiolabeled S. venezuelae
DNA fragments encompassing the promoter regions of two
well-characterized BldD target genes, bldM and whiG, including
the bioinformatically identified BldD box (Figure 2C), were used
as target DNAs in electrophoretic mobility shift assays (EMSAs)
(Figure 2D). The fixed concentration of BldD used in these assays
(0.6 mM) was insufficient to elicit a DNA mobility shift. However,
the addition of increasing concentrations of c-di-GMP (0.25–
1.75 mM) strongly induced BldD binding to both the tested
promoter regions (Figure 2D). To confirm and extend these re-
sults into cells, we manipulated the levels of c-di-GMP in
S. venezuelae and monitored the effect on BldD binding to the
bldM and whiG promoters in vivo using ChIP-sequencing
(ChIP-seq). The degree of BldD binding was assayed at a single
time point inWT S. venezuelae and theWT overexpressing either
the DGC CdgB or the PDE YhjH (the strains whose phenotypes
are described above). Consistent with the in vitro EMSA data,
overexpression of the DGC enhanced ChIP-seq peak height at
Figure 2. The BldD CTD Binds c-di-GMP and Activates DNA Binding
(A) Schematic showing the domain organization of the BldD protein. BldD contains an N-terminal DBD connected by a flexible linker to a CTD.
(B) Results of DRaCALAs assays carried out using purified FL His6-BldD, His6-BldD-DBD or His6-BldD-CTD, and
32P-labeled c-di-GMP. The TetR-like regulator
SVEN_1547 and the active DGC PleD* from C. crescentus served as negative () and positive (+) controls, respectively (top row). In competition DRaCALAs,
excess cold c-di-GMP or GTP was added to the binding reaction containing 32P-labeled c-di-GMP and His6-FL BldD or His6-BldD-CTD. c-di-GMP binding is
indicated by dark spots centered on the nitrocellulose.
(C) Top: the DNA consensus motif bound by BldD (den Hengst et al., 2010). Below are the sequences from the S. venezuelae bldM and whiG promoter regions
(with BldD-binding boxes in bold). The transcriptional start sites are indicated by bent arrows.
(D) EMSA analyses of BldD binding to the bldM andwhiG promoters ± c-di-GMP. Free DNA and protein-DNA complexes (bound DNA) are indicated with arrows.
(E) In vivo BldD ChIP-seq data for bldM and whiG. Color coding of the ChIP samples is as follows: WT S. venezuelae (red), S. venezuelae overexpressing the
S. coelicolorDGCCdgB (green), and S. venezuelae overexpressing the E. coli PDE YhjH (blue). Plots span3 kb of DNA sequence. Genes running left to right are
shown in green, and genes running right to left are shown in red.the BldD target promoters relative to the WT control (Figure 2E).
Conversely, overexpression of the PDE lowered ChIP-seq peak
heights at BldD target promoters relative to the WT (Figure 2E).
These data demonstrate that c-di-GMP enhances the binding
of BldD to the BldD box, stimulating BldD-mediated repression
of its target regulon. Thus, it is not BldD, but a BldD-(c-di-
GMP) complex, that serves to turn off sporulation genes during
vegetative growth.
S. venezuelae bldDMutants Show an Accelerated
Sporulation Phenotype that Bypasses Aerial
Mycelium Formation
The opposing effects of the overexpression of the DGC CdgB
and the PDE YhjH suggested that high levels of c-di-GMP retard
sporulation and low levels of c-di-GMP accelerate sporulation.
Because the BldD-(c-di-GMP) complex serves to keep sporula-tion genes shut off during vegetative growth, loss of BldD should
have a similar effect on Streptomyces development as depletion
of c-di-GMP levels. To test this hypothesis, we deleted bldD from
the S. venezuelae chromosome. Strikingly, the bldD null mutant
formed small colonies lacking aerial hyphae, but—when exam-
ined by SEM—even young colonies of the bldD mutant were
found to contain spore chains embedded in an excess of extra-
cellular matrix (Figure 3A). Heat resistance tests showed the bldD
mutant spores were mildly defective (Figure S1A). By contrast,
equivalent young colonies of theWT that were grown and imaged
in parallel had not yet developed aerial hyphae or spores (Fig-
ure 3B). Thus, loss of BldD mimics the effects of overexpressing
the PDE YhjH (compare Figures 1C and 3A). In addition, overex-
pression of CdgB had no effect on the phenotype of the bldD
mutant (Figure S2A), further supporting the idea that c-di-GMP
signals through BldD to control the hypha-to-spore transition.Cell 158, 1136–1147, August 28, 2014 ª2014 The Authors 1139
Figure 3. BldD-Deficient Cells Show an
Enhanced Sporulation Phenotype
(A and B) SEMs showing that a constructed
S. venezuelae DbldD mutant (A) exhibits acceler-
ated sporulation compared to the WT (B). At 36 hr
the WT strain consists of pure vegetative myce-
lium. Strains were grown on MYM agar for 36 hr at
30C prior to imaging.
See also Figure S2A.Crystal Structures of BldD CTD-(c-di-GMP) Complexes:
Small-Molecule-Mediated Protein Dimerization
To elucidate the molecular basis for c-di-GMP recognition and
binding by the BldD CTD and to gain insight into how this inter-
action may elicit developmental signaling, we determined struc-
tures of the S. venezuelae BldD CTD (residues 80–166) and
S. coelicolor BldD CTD (residues 80–167) in complex with c-di-
GMP. Three S. venezuelae BldD C-domain-(c-di-GMP) struc-
tures and one S. coelicolor BldD C-domain-(c-di-GMP) structure
were determined to resolutions of 1.95 A˚, 2.33 A˚, 1.75 A˚, and
2.25 A˚, respectively (Figure 4) (see Extended Experimental Pro-
cedures and Tables S1 and S2).
The BldD CTD structures are composed of two (b-a-a) repeats
followed by a short C-terminal helix and are similar to the apo
form studied by NMR (Kim et al., 2014) (Figure 4). Database
searches revealed that the BldD CTD harbors a new fold, but
reduced stringency revealed that it shows limited structural sim-
ilarity with winged HTH proteins, in particular, the winged HTH
domain of eukaryotic heat shock factor 1 (HSF1) (Littlefield and
Nelson, 1999). The BldD CTD and HSF1 bind c-di-GMP and
DNA, respectively, but the motifs they employ to interact with
their nucleotide ligands are completely different (Figure S3).
The BldD CTD uses a previously unseen mode of c-di-GMP
binding in which two noninteracting CTDs are glued together
by a c-di-GMP tetramer composed of two interlocked c-di-
GMP dimers (Figure 4A). Thus, in the BldD CTD-(c-di-GMP)
complex, c-di-GMP functions as a macromolecular dimerizer.
Indeed, the closest approach of any Ca atoms of the two teth-
ered CTDs is 10 A˚.
The BldD CTD interacts with c-di-GMP using two contiguous
surface motifs, herein called motif 1 and motif 2, which are
located between the two b-a-a repeats. Motif 1 is composed
of residues 114–116 (RGD) and motif 2 is composed of residues
125–128 (RQDD) (Figure 5A). These motifs are located on a sol-
vent exposed region at one end of each CTD protomer and not
within a pocket or cavity (Figures 4A and 5A). The combined mo-
tifs from two CTD subunits provide ideal shape and electrostatic
complementarity for encasing the unusual cage-like c-di-GMP
tetramer (Figures 4A and 4B). Strikingly, although the BldD
CTD is overall acidic (pI5.0), the c-di-GMP-binding surface be-
tween two BldD protomers is electropositive (Figure 4B). In addi-
tion to shape and charge complementary, contacts from the
arginine and aspartic acid residues within motifs 1 and 2 provide
specificity for recognition of guanine cyclic nucleotides; the mul-
tiple interactions effectively exclude binding to adenine cyclic
nucleotides. Specifically, motif 2 from each CTD protomer
combine to mediate contacts to one intercalated c-di-GMP1140 Cell 158, 1136–1147, August 28, 2014 ª2014 The Authorsdimer, Asp116 of motif 1 from each protomer combine to
mediate contacts to the other c-di-GMP dimer, while Arg114
sits centrally and anchors both dimers (Figures 5A and 5B).
The guanine bases wedged between the two motif 2 regions
are specified by contacts from residues Arg125 and Asp128 (Fig-
ures 5A and 5B). Residue Asp128makes two hydrogen bonds to
the N1 and the exocyclic N2 atoms of the guanine bases on each
end (top and bottom layers) of the intercalated dimer, while
Arg125 flanks the guanines in the center (middle layers) of the
dimer and makes hydrogen bonds to the guanine O6 and N7
atoms (Figures 5B–5D). The O6 moiety is also specified by the
backbone nitrogen of Arg125. Notably, the stacking interactions
between the Arg125 side chains are the only direct contacts be-
tween the two CTD protomers but are clearly not sufficient to
promote BldD dimerization.
Arg114 is the only CTD residue that makes contacts to both
intercalated c-di-GMP dimers. Arg114 hydrogen bonds to the
guanines contacted by Asp128, as well as the O6 atoms of the
adjacent guanines of the other c-di-GMP dimer (Figures 5A
and 5B). Thus, Arg114 plays a key role in the recognition and sta-
bilization of this unique c-di-GMP tetramer. The c-di-GMP dimer
bound between the motif 1 regions has fewer contacts and is
more exposed (Figure 5A). In addition to contacts from Arg114,
Asp116 of motif 1 hydrogen bonds to the guanine N1 and N2
atoms in a manner analogous to the contacts from Asp128 of
motif 2 (Figure 5). Notably, the specific hydrogen bonds from
motif 1 and 2 residues to guanine exocyclic O6 and N2 atoms
dictate that BldD binds to c-di-GMP but not to c-di-AMP, which
is missing an exocyclic atom at the 2 position and harbors a
hydrogen bond donor rather than an acceptor at the exocyclic
6 position. BldD motifs 1 (RXD) and 2 (RXXD), although similar
in sequence to the inhibitory I-site (RXXD), which is involved in
product inhibition feedback control of DGC activity (Christen
et al., 2006), are structurally different. Further, mutagenesis of
either BldD motif 1 or motif 2 abolishes c-di-GMP binding in
DRaCALA assays (Figure S2B), confirming that, unlike I-site
c-di-GMP binding, both motifs 1 and 2 in BldD are required to
construct the complete binding site for the tetrameric c-di-
GMP complex. This dual signature sequence is unlike any previ-
ously characterized c-di-GMP-binding motif. Moreover, specific
binding of the c-di-GMP tetramer requires encasement by two
such bipartite motifs from precisely oriented BldD protomers.
While the arginine and aspartic acid residues in BldD motifs 1
and 2 dictate the c-di-GMP-binding arrangement and read the
guanine bases, contacts to the c-di-GMP phosphate groups
are provided by Lys84 from b1 and Arg130 from a3. Further,
Ile110 makes van der Waals interactions and residues Asn118
Figure 4. Structures of BldD CTD-(c-di-GMP) Complexes Reveal a Unique c-di-GMP Oligomer and c-di-GMP-Mediated Dimerization
Mechanism
(A) Ribbon diagram of the S. venezuelaeBldD CTD-(c-di-GMP) complex. Secondary structural elements of CTD2 are labeled. The c-di-GMP tetramer is shown as
sticks with each c-di-GMP molecule colored differently. Ribbon diagrams were made using PyMol (Delano, 2002).
(B) Electrostatic surface representation of the BldD CTD-(c-di-GMP) complex. Blue and red represent electropositive and electronegative surfaces, respectively.
The four c-di-GMP molecules are colored as in (A).
(C) Composite 2Fo-Fc omit map of the 1.75 A˚ BldD CTD-c-di-GMP complex contoured at 1s around the central nucleotides of the c-di-GMP tetramer.
(D) Superposition of all 12 Bld CTD-(c-di-GMP) complexes (rainbow colored) determined in this study.
See also Figures S3 and S4 and Tables S1 and S2.and Ser123 hydrogen bond with the guanine bases on the top
and bottom layers of the c-di-GMP tetramer (Figure 5A). The
combination of the optimally positioned bipartite signature se-
quences from two BldD protomers exquisitely templates binding
of the specific and unusual c-di-GMP tetramer structure.
The BldD-(c-di-GMP) Structure Reveals a Tetrameric
Form of the c-di-GMP Second Messenger
c-di-GMP is monomeric in solution at physiological concentra-
tions (Gentner et al., 2012). However, intercalated c-di-GMP di-
mers have been observed in crystal structures of the nucleotide
alone and in complexes with effector proteins. Higher order c-di-
GMP structures such as tetramers and octamers have thus far
only been inferred from NMR and spectroscopic studies and
require very high c-di-GMP concentrations (up to 30 mM) and
monovalent cations (Zhang et al., 2006). These higher order
structures are characterized by G-quartet interactions with a
centrally bound potassium ion coordinated by four guanines.
There are minimal base contacts and no base stacking interac-
tions in these structures (Figure S4A) (Zhang et al., 2006; Gentner
et al., 2012). By sharp contrast, the BldD-bound tetrameric c-di-
GMP is a tightly packed structure that is not secured by ions.
Rather, the c-di-GMP molecules are closely spaced and opti-
mally positioned for interbase pairing, leading to the formation
of a multistranded, base-stacked structure with top, middle,
and bottom layers (Figures 5D and S4A). There are 12 hydrogenbonds between the two intercalated dimers within the c-di-GMP
tetramer, including contacts between the N3 atoms and exocy-
clic NH2 amides of an adjacent base (Figures 5C and S4B). Such
contacts could not be formed with c-di-AMP due to its lack of an
exocyclic NH2 atom. Therefore, in addition to contacts from mo-
tifs 1 and 2, guanine-guanine base hydrogen bonds serve to
specify c-di-GMP tetramer binding to BldD. Notably, formation
of the c-di-GMP tetramer buries 24% of the total surface area
(buried surface area [BSA]) of the c-di-GMP molecules (Figure
S4B). By comparison, in most protein oligomers the BSA be-
tween protomers is 15% (Wang et al., 2009). Finally, the inter-
face between the intercalated c-di-GMP dimers that forms the
tetramer is remarkably complementary in shape (Figure S4B).
Thus, the combination of multiple contacts between the c-di-
GMPmoieties along with its extensive BSA andmolecular shape
complementarity lead to the creation of a compact and highly
specific c-di-GMP tetramer. However, BldD is necessary to sta-
bilize this tetramer and template its formation.
c-di-GMP Induces Dimerization of the BldD CTD
in Solution
The BldD CTD-(c-di-GMP) crystal structures reveal that c-di-
GMP acts as a ‘‘dimerizer’’ to link two CTD protomers. To
examine the effect of c-di-GMP on the oligomeric state of the
BldD CTD in solution, we carried out chemical crosslinking
and size exclusion chromatography (SEC) studies. ChemicalCell 158, 1136–1147, August 28, 2014 ª2014 The Authors 1141
Figure 5. The BldD CTD Contains a c-di-GMP-Binding Signature Composed of Two Contiguous Motifs
(A) Structure of the BldD dimer-(c-di-GMP) complex. Top: the location of the two c-di-GMP-binding motifs (motif 1 and motif 2) of the bridged CTD promoters.
Middle: a close-up of selected residues of the BldD CTD that interact with the c-di-GMP nucleotides. Bottom: alignment of the sequences of the S. venezuelae
and S. coelicolor BldD CTDs. Motif 1 is colored cyan and motif 2 is magenta. Other residues that contact c-di-GMP are colored yellow.
(B) Close-up of the top and bottom layer CTD-(c-di-GMP) contacts, including the Arg114 side chain-guanine interactions, which anchor the two intercalated
dimers together.
(C) Close-up of the central or middle layers of the two intercalated c-di-GMP dimers. Shown are the hydrogen bonds from R125 and one guanine and those
between the N2 and N3 atoms of two guanines from different c-di-GMP dimers that tether the intercalated dimers in these layers.
(D) Side view of the c-di-GMP layers, highlighting the multiple base-base, side chain-base, and side chain-side chain stacking interactions that stabilize the c-di-
GMP tetramer structure. Base stacking is depicted by appropriately colored solid lines.
See also Figures S2B, S5, and S7 and Tables S1 and S2.crosslinking experiments were performed using disuccinimidyl
suberate (DSS), which contains amine-reactive N-hydroxysucci-
nimide esters at both ends of an 11 A˚ spacer arm. This reagent
should therefore be able to crosslink even the distantly anchored
CTD protomers observed in our CTD-(c-di-GMP) structures
(Figure 4A). In the absence of DSS, the BldD DBD and CTD
migrate on SDS-PAGE gels as single bands with the expected
monomeric molecular weights of 11 and 12 kDa, respectively
(Figure 6A). Upon incubationwithDSS, theBldDDBD forms a co-
valent dimer of 21 kDa, consistent with previous biochemical
and structural analyses of this domain (Kim et al., 2006; Lee
et al., 2007a), and oligomerization is unaffected by the addition
of c-di-GMP (Figure 6A). By contrast, the BldD CTD remains
monomeric after DSS addition. However, in the presence of
c-di-GMP, addition of DSS results in the clear formation of cova-
lent CTD dimers (Figure 6A).
To examine c-di-GMP-induced CTD oligomerization further,
we performed SEC analyses. As part of this study, we mutagen-
ized the RGD (motif 1)-X8-RQDD (motif 2) c-di-GMP-binding1142 Cell 158, 1136–1147, August 28, 2014 ª2014 The Authorssignature of the BldD CTD. To retain the charge of these surface
residues, we made the charge-swapped DGR-X8-DQDR CTD
mutant, changing the key Arg residues within the two motifs to
Asp, and vice versa. DRaCALA assays showed that this mutant
CTD was unable to bind c-di-GMP (Figure S2B). SEC experi-
ments in the presence of 3 mM c-di-GMP showed that the WT
CTD forms a dimer, while the mutant CTD is monomeric (Fig-
ure 6B). Hence, the crosslinking and SEC data support our struc-
tural finding that c-di-GMP is required for BldDCTDdimerization.
Further, we constructed a bldDmutant allele encoding a protein
solely defective in c-di-GMP binding (carrying the DGR-X8-
DQDR mutation) and found that it had no ability to complement
abldDmutant (FigureS2A), confirming that themajor in vivo func-
tions of BldD are indeed mediated by its binding to c-di-GMP.
Affinity, Stoichiometry, and Specificity of c-di-GMP
for BldD CTD
Our structures reveal a unique interaction between the BldDCTD
and a c-di-GMP tetramer. Remarkably, every guanine in this
Figure 6. c-di-GMP Is Required for BldD CTD Dimerization in
Solution
(A) DSS chemical crosslinking. We crosslinked 10 mM His6-BldD-DBD
(10.7 kDa) or His6-BldD-CTD (12.0 kDa) by using 1 mMDSS in the presence or
absence of 20 mMc-di-GMP as indicated. In control reactions, the DSS solvent
dimethylsulfoxide (DMSO) alone was added to the proteins. Samples were
analyzed by SDS-PAGE. Monomers and dimers of each BldD domain are
marked by arrows.
(B) SEC analysis of the WT BldD CTD and BldD CTD DGR-X8-DQDRmutant in
the presence of 3 mM c-di-GMP. The WT CTD + c-di-GMP is dimeric, while the
quadruple mutant is monomeric. The standard curve was determined using
cytochrome C (12 kDa), carbonic anhydrase (29 kDa), and albumin (66 kDa)
(green circles).complex is read specifically by either BldD arginines, aspartic
acids, and/or other guanine bases, suggesting that BldD binds
only c-di-GMP, and not other cyclic nucleotides. To test this hy-
pothesis and further probe the c-di-GMP-binding affinity of
BldD, we performed fluorescence polarization (FP) experiments.
These studies were performed with BldD CTD that was ex-
pressed and purified from Sf9 insect cells to ensure no c-di-
GMP was present, as eukaryotes do not produce c-di-GMP
(Extended Experimental Procedures). The BldD-(c-di-GMP)
structures show that one ribose of each c-di-GMP bound to
BldD must be unmodified to permit formation of the BldD-
(c-di-GMP) complex (Figure S5A). Hence, for these studies we
used the fluoresceinated probe, 20-Fluo-AHC-c-di-GMP, which
harbors the fluorescein dye on only one ribose (Figure S5A).
These studies revealed BldD CTD bound to 20-Fluo-AHC-c-di-
GMP, with an apparent Kd of 2.5 mM ± 0.6 (Figure S5B). Consis-tent with our DRaCALA assays (Figure S2B), the DGR-X8-DQDR
CTD mutant failed to bind 20-Fluo-AHC-c-di-GMP in FP assays
(Figure S5B). WT BldD CTD showed no binding to the identically
fluoresceinated c-di-AMP tagged molecule, 20-Fluo-AHC-c-di-
AMP (Figure S5B).
Next, to ascertain the stoichiometry of c-di-GMPbinding in so-
lution, we used an FP-based binding assay. The resulting data
(Figure S5C) show a linear increase in fluorescence polarization
until saturation of the binding sites. A single inflection point can
be fitted at a BldD monomer concentration of 12 mM, which
equates to a stoichiometry of four c-di-GMP molecules per
CTD dimer. However, careful inspection of the data reveals
another potential inflection point at a BldD monomer concentra-
tion of 6 mM, which would be consistent with an initial binding
event of two c-di-GMP molecules per CTD dimer. This putative
initial binding event is also apparent in the equilibrium-binding
isotherm yielding an apparent Kd of 1.7 mM (Figure S5B).
Two-step binding is not inconsistent with the structure, but the
nearly identical affinities observed for each binding event sug-
gest positive cooperativity. Overall, these data demonstrate
unequivocally that c-di-GMP binds the CTD with a stoichiometry
of four c-di-GMP molecules per CTD dimer, concordant with
our structures. These studies also demonstrate that the BldD
CTD binds specifically and with high affinity to c-di-GMP but
not c-di-AMP and that both motifs 1 and 2 are essential for this
interaction.
The Mechanism for (c-di-GMP)-Activated DNA
Binding by BldD
Dimeric BldD binds pseudo-palindromic DNA sites that contain a
50-TNAC(N)5GTNA-30 consensus (den Hengst et al., 2010). Our
data and those of others (Lee et al., 2007a) show that the BldD
DBD alone can dimerize at higher concentrations (R10 mM).
Consistent with these findings, the crystal structure of the
S. coelicolor BldD DBD revealed a dimer with a small contact
interface (Kim et al., 2006). We obtained additional views of the
BldD DBD by solving the S. venezuelae BldD DBD structure to
2.80 A˚ resolution. This structure contained two DBD dimers in
the asymmetric unit. Comparison of these dimers with the dimer
from the S. coelicolor DBD structure showed that, although hy-
drophobic residues within the C-terminal regions of the DBDs
make contacts between the subunits in each case, all three di-
mers take distinct conformations (Figure S6A). Moreover, there
is less than 300 A˚2 BSA per subunit in this dimer, which is far
less than the 1000 A˚2 BSA per subunit typically observed for bio-
logically relevant dimers (Krissinel and Henrick, 2007). These
data indicate that the BldD DBD is unlikely to form a stable
DNA-binding active dimer at physiologically relevant concentra-
tions. In addition, although the BldD DBD resembles the equiva-
lent DBD of l repressor, previous modeling studies suggested
that the BldD DBDs would not interact specifically with DNA if
BldD employed a DNA-bindingmechanism similar to that utilized
by l repressor (Kim et al., 2006). Thus, it has been unclear how
BldD binds cognate DNA. Our finding that c-di-GMP binding
leads to the formation of a c-di-GMP bridged CTD dimer pro-
vides the missing link to this puzzle. However, how c-di-GMP
binding to the CTDs is signaled to the DBDs to bring about
DNA binding remained unclear.Cell 158, 1136–1147, August 28, 2014 ª2014 The Authors 1143
Figure 7. TheMolecular Mechanism of c-di-
GMP-ActivatedDNABinding byBldD and Its
Control of Streptomyces Development
(A) Structure of the S. venezuelae BldD-(c-di-
GMP)-DNA complex. One protomer is colored red
and the other green. The c-di-GMP molecules are
shown as sticks and the DNA as a cartoon. The
linker region between the DBD and CTD (red or
green dashed lines) is disordered in both proto-
mers, indicating their conformational flexibility.
(B) Electrostatic surface representation of the
BldD-(c-di-GMP)-DNA structure shown in the
same orientation as (A).
(C) Schematic model of c-di-GMP-mediated acti-
vation of high affinity DNA binding by BldD, leading
to repression of Streptomyces development. The
BldD CTD is shown as ovals and the DBD as
squares. The DBDs interact only weakly in vivo
(indicated by the double-headed arrow). In-
creased c-di-GMP levels lead to BldD CTD
dimerization, resulting in a significant increase in
the local concentration of the DBDs, allowing them
to dimerize optimally in the presence of cognate
DNA to effect high affinity DNA binding. This leads
to repression of the BldD regulon, thus blocking
multicellular differentiation.
See also Figure S6 and Table S2.Todeduce themechanismbywhichc-di-GMPactivatesBldD to
bind DNA, we determined the structure of a BldD-(c-di-GMP)-21-
mer DNA complex to 4.5 A˚ resolution (Extended Experimental
Procedures; Figure S6B). While the low resolution of the structure
precludes a detailed analysis, the electron density maps show
the overall arrangement of the domains and how the DBDs dock
onto the DNA. Critically, the structure reveals that BldD binding
to cognate DNA is more similar to the DNA binding mode of the
XRE protein SinR (Lewis et al., 1998; Newman et al., 2013) than
to that of the l repressor, as the two BldD DBDs are juxtaposed
whenBldD isbound toDNA (Figures7Aand7B). TheDBD-DBD in-
teractingsurfacesobserved in theBldD-DNAcomplexcorrespond
to the hydrophobic regions near the DBD C terminus that interact
in the apo DBD structures. However, the interfaces are yet again
different, supporting the notion that DBD dimerization is weak
and malleable. Such malleability is critical to allow the dimeric
BldD HTH elements to bind the DNA, which is bent by30.
The BldD DBDs are tethered to the CTD via a linker that was
previously shown to be highly flexible (Kim et al., 2006; Lee
et al., 2007a). Not surprisingly, this linker (PGTTPGGAAEPPP;
residues 71–84) is disordered in the BldD-(c-di-GMP)-21-mer
structure. Its flexibility is underscored by the different orientation
of the two CTDs in the structure relative to the DBD-DNA com-
plex (Figure 7A). The CTD subunits in the dimermake different in-
teractions that help anchor them in the BldD-(c-di-GMP)-DNA
crystal; one of the CTDs interacts with a hydrophobic patch on
its cognate DBD, while the other CTD makes crystal contacts
with a symmetry mate (Figures 7A and S6C). However, the
CTDs in the FL BldD-(c-di-GMP)-DNA structure are dimerized
in a manner identical to that observed in our CTD-(c-di-GMP)
structures (Figures 4D, 5A, 7A, and S6C).
Additional evidence that the linker region between the DBD
andCTD is flexible was provided by proteolysis experiments em-1144 Cell 158, 1136–1147, August 28, 2014 ª2014 The Authorsploying Endoproteinase Glu-C, which cleaves exposed peptide
bonds on the carboxyl side of glutamic or aspartic acid residues.
Hence, if the BldD linker region is unstructured, Glu-C should
selectively cleave after BldD residue Glu80. Glu-C proteolysis
experiments were carried out on the FL BldD protein, the FL pro-
tein with the 21-mer DNA present, and the FL protein in the pres-
ence of both c-di-GMP and the 21-mer DNA. In all three cases
BldD was readily cleaved into two bands, corresponding to the
DBD and the CTD (Figure S6D). Thus, neither the presence of
DNA, nor of c-di-GMP and DNA, protected BldD from proteoly-
sis, indicating the linker is exposed even in the presence of
cognate ligands. Therefore, the combined data suggest amolec-
ular model for c-di-GMP activation of BldD DNA binding in which
binding of c-di-GMP leads to the formation of a c-di-GMP-linked
BldD CTD dimer (Figure 7C). Such CTD dimerization effectively
brings the twoDBDs into proximity, thereby increasing their local
concentration to allow germane DBD dimerization on cognate
DNA (Figure 7C). The inherent flexibility afforded by the DBD-
CTD linker allows the DBDs to adjust for optimal binding to mul-
tiple pseudo-palindromic BldD DNA boxes.
DISCUSSION
The role of c-di-GMP has been studied extensively in unicellular
Gram-negative bacteria, in which most c-di-GMP-dependent
signaling pathways control the transition from a planktonic,
motile lifestyle to a surface-associated, sessile lifestyle (‘‘stick
or swim’’). Here we show that the activity of the Streptomyces
master regulator BldD is also controlled by c-di-GMP, thus
bringing the regulatory role of this key second messenger into
a new physiological arena, that of differentiation in Gram-posi-
tive multicellular bacteria. Our studies indicate that c-di-GMP
binding to BldD controls the developmental switch between
vegetative growth and sporulation. Specifically, we demonstrate
that c-di-GMPbinding to BldD activates its DNA-binding activity,
which results in repression of sporulation genes during vegeta-
tive growth. Consistent with this, genetic studies revealed that
bldD null mutants sporulate precociously, mimicking the effect
of overexpressing a c-di-GMP phosphodiesterase. Thus, c-di-
GMP signals through BldD to control the hypha-to-spore devel-
opmental transition in Streptomyces.
Few c-di-GMP effector-binding motifs have been identified to
date. These include I-site motifs (Duerig et al., 2009; Lee et al.,
2007b; Petters et al., 2012), inactive EAL domains (Navarro
et al., 2009; Qi et al., 2011; Newell et al., 2009), and PilZ domains
(Amikam and Galperin, 2006). Structures have shown that c-di-
GMP interacts with these motifs as either a monomer or interca-
lated dimer. The BldD protein does not contain any previously
characterized c-di-GMP effector-binding motifs. Thus, to eluci-
date the mechanism by which c-di-GMP acts as a switch to
turn on the DNA-binding activity of BldD, we determined several
structures of the BldD CTD complexed to c-di-GMP as well as a
4.5 A˚ structure of the BldD-(c-di-GMP)-DNA complex. These
structures revealed that BldD interacts with c-di-GMP using a
heretofore unseen c-di-GMP binding mode involving a unique
c-di-GMP-binding signature sequence consisting of two prox-
imal arginine and aspartic acid containing motifs, motif 1 (RXD)
and motif 2 (RXXD), separated by eight residues. Remarkably,
in this bindingmode, a tetrameric form of the c-di-GMP functions
as a small-molecule dimerizer to adjoin two noninteracting
BldD protomers. Notably, the identical CTD dimer-(c-di-GMP)
tetramer structure was seen in multiple crystal forms. Finally,
binding studies confirmed that the BldD CTD binds c-di-GMP
with a stoichiometry of four c-di-GMP molecules to one BldD
CTD dimer. The c-di-GMP tetramer revealed in these structures
represents a previously unknown form of this nucleotide second
messenger. Indeed, we do not know of any other example in
which a signaling molecule can assume different oligomeric
states to effect its function.
BldD is present throughout the sporulating actinomycetes
(den Hengst et al., 2010), including, for example, nitrogen-fixing
Frankia that live in symbiosis within the root nodules of alder
trees, and members of the marine genus Salinospora, which
have recently emerged as an important source of antibiotics
and other medically significant compounds. Outside of the
genus Streptomyces, the only actinomycete in which BldD has
been investigated is Saccharopolyspora erythraea, where BldD
directly controls expression of the biosynthetic cluster of the
clinically important antibiotic erythromycin (Chng et al., 2008).
Homologs from across the sporulating actinomycetes share
77%–99% sequence identity with S. venezuelae BldD. The
main region of conservation between these proteins is the N-ter-
minal DNA-binding domain, which shares 95%–100% identity.
Although our BldD-(c-di-GMP)-DNA structure is too low resolu-
tion to ascribe specific protein-DNA contacts, it reveals the loca-
tion of the HTH motif and residues that likely contact the DNA.
Notably, these amino acids are the most conserved among
BldD homologs (essentially 100%; Figure S7). By contrast, the
CTD regions of BldD proteins are less well conserved (as low
as 48% identity). Hence, it is striking, given this low conservation,
that the residues that interact with c-di-GMP are strictlyconserved (Figure S7). The only exception is Lys84, which con-
tacts c-di-GMP phosphate groups. However, in all BldD homo-
logs this residue is either a lysine or arginine and thus able to
make the same electrostatic interaction. Of particular note, res-
idues R114, D116, R125, and D128 (from motifs 1 and 2), which
mediate essential specifying contacts with c-di-GMP, are
conserved in all homologs (Figure S7). Further, all of the actino-
mycetes that encode an ortholog of BldD also encode GGDEF
domain-containing DGCs. These combined findings indicate
that BldD-(c-di-GMP) is likely to control key developmental pro-
cesses throughout the sporulating actinomycetes, using tetra-
meric c-di-GMP as a second messenger.
EXPERIMENTAL PROCEDURES
For a full explanation of the experimental protocols, see Extended Experi-
mental Procedures in Supplemental Information.
Bacterial Strains, Plasmids, and bldD Null Mutant Construction
Strains and plasmids used are shown in Table S3, and oligonucleotides used
are shown in Table S4. Plasmids were constructed as described in Extended
Experimental Procedures. A bldD null mutant (SV77) was constructed by Redi-
rect PCR targeting, and the bldD::aprmutant allele was moved into a new WT
background by generalized transduction using the S. venezuelae-specific
phage SV1. Transduction of the bldD::apr allele was confirmed by PCR and
the strain was named SV74.
Capture of c-di-GMP-Binding Proteins and Differential Radial
Capillary Action of Ligand Assays
Cyclic di-GMP capture compound experiments were performed as described
previously (Nesper et al., 2012) but with the minor modifications described in
Extended Experimental Procedures. Briefly, the c-di-GMP capture compound
was added to the soluble lysates and, following UV irradiation in the caproBox,
magnetic streptavidin beads were added to the reaction. After incubation
the beads were collected, washed, and boiled in sample buffer, the proteins
releasedwere run on SDS-PA gels and cut out for mass spectrometry analysis.
The DRaCALA assays used His6-BldD or N-terminally His-tagged domains,
which were incubated with 11 nM 32P-c-di-GMP. The competition ex-
periments had 266 mM cold c-di-GMP or GTP added to the reaction. Sam-
ples were spotted onto nitrocellulose membranes and analyzed using
Phosphorimaging.
DNA-Binding Assays: EMSA and ChIP-Seq Experiments
DNA fragments spanning the bldM (158 bp) and whiG (151 bp) promoter re-
gions of S. venezuelae were generated by PCR and 50 end labeled using
[g32-P]-ATP and T4 polynucleotide kinase. The binding reactions were per-
formed using 0.6 mM His6-BldD and radiolabeled DNA (8,000 cpm) as well
as 0.5 mg poly[d(I-C)] as nonspecific competitor DNA. When appropriate,
increasing amounts of c-di-GMP (0.25–1.75 mM) were added to the mixture.
The reaction samples were incubated for 20 min at room temperature and
then run on 5% polyacrylamide gels. Chromatin immunoprecipitations were
performed as described (Bush et al., 2013) using an anti-BldD polyclonal
antibody.
Biochemical Studies on BldD Oligomeric State
The oligomeric states of BldD and its domains were analyzed via chemical
crosslinking using DSS in the presence and absence of c-di-GMP (see the
Extended Experimental Procedures) and visualized on SDS-PA gels. Molecu-
lar weight analyses using SEC experiments were performed with a HiLoad 16/
600 Superdex 75 pg column.
Crystallization and Structures Determination of BldD Complexes
For detailed descriptions of the protein expression, purification, crystallization,
structure determination, and refinement protocols, see the Extended Experi-
mental Procedures.Cell 158, 1136–1147, August 28, 2014 ª2014 The Authors 1145
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